Bernstein Reiterates Outperform Rating on Elevance Health Inc. (ELV)

Market Context

Elevance Health Inc. operates in the Healthcare sector. The stock currently trades at $420.20 with a market capitalization of $80.0B. The stock has gained 31.4% over the past 52 weeks.

Analyst coverage from Bernstein provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Elevance Health Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Elevance Health Inc.

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 02, 2026	Bernstein	Outperform	N/A
Jun 08, 2026	JP Morgan	Overweight	N/A
Jun 08, 2026	Mizuho	Outperform	N/A
Jun 04, 2026	Morgan Stanley	Equal-Weight	N/A
Jun 04, 2026	B of A Securities	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View ELV Stock Page